Drugs / Trivalent influenza vaccine(B/V)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04363359 Comparator | Jan 2020 → Sep 2021 | influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent influenza vaccine(B/V) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04363359 ↗ |
| Modality | Vaccine | “The inactivated split virion vaccines contained 7.5 μg of each hemagglutinin antigen of influenza A/H1N1, A/H3N2 and B/Victoria strains” NCT04363359 ↗ |